111 related articles for article (PubMed ID: 33962997)
21. Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma.
Chen CW; Torng PL; Chen CL; Chen CA
World J Surg Oncol; 2013 Oct; 11():255. PubMed ID: 24088247
[TBL] [Abstract][Full Text] [Related]
22. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
[TBL] [Abstract][Full Text] [Related]
23. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
24. Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases.
Cheng B; Lu W; Xiaoyun W; YaXia C; Xie X
Int J Gynecol Cancer; 2009 May; 19(4):611-4. PubMed ID: 19509558
[TBL] [Abstract][Full Text] [Related]
25. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.
Ren Y; Dai C; Zheng H; Zhou F; She Y; Jiang G; Fei K; Yang P; Xie D; Chen C
Oncotarget; 2016 Aug; 7(33):53245-53253. PubMed ID: 27449299
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
[TBL] [Abstract][Full Text] [Related]
27. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathological features and prognosis of patients in endometrial cancer with bone metastases].
Jiang F; Ren T; Cheng NH; Cao DY; Yang JX; Wu M; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):452-457. PubMed ID: 31365957
[No Abstract] [Full Text] [Related]
29. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
30. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
31. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
[TBL] [Abstract][Full Text] [Related]
32. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
33. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
[TBL] [Abstract][Full Text] [Related]
35. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
[TBL] [Abstract][Full Text] [Related]
36. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
37. An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy?
Komatsu T; Kunieda E; Oizumi Y; Tamai Y; Akiba T
Neoplasma; 2012; 59(6):650-7. PubMed ID: 22862159
[TBL] [Abstract][Full Text] [Related]
38. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
[TBL] [Abstract][Full Text] [Related]
39. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
40. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]